Paul Hastings (Europe) LLP advised Keensight Capital in connection with the acquisition of Inke, a specialized inhalation active pharmaceutical ingredients (APIs) developer and manufacturer, previously owned by the Neuraxpharm Group.

Corporate partner Olivier Deren led the Paul Hastings team, which also included associate Vincent Nacinovic on contractual and corporate aspects, as well as partner Allard de Waal on the tax aspects.

More details on the transactions can be found here.

About Paul Hastings

With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment, and real estate, Paul Hastings is a premier law firm providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers, and corporations.